Nyrada Quarterly Activities Report & Appendix 4C
Highlights: • Cholesterol-Lowering Program advances: – New data from in vivo cholesterol study showed NYX-PCSK9i significantly increased plasma PCSK9 levels,… Read more
Incannex engages Procaps to manufacture IHL-42X soft-gel capsules in preparation for pivotal clinical trials
Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL, ‘Incannex’ or the ‘Company’), is pleased to announce that it… Read more
HTG expands ecosystem with Inmarsat Global
HIGHLIGHTS: • Harvest Technology Group has signed a Memorandum of Understanding with Inmarsat Global as a development partner for Inmarsat’s… Read more
HTG strikes reseller deal with global satellite provider Speedcast
Harvest Technology Group Limited (ASX:HTG) (Company, Group, Harvest), a global leader in network optimised remote operations, is pleased to announce… Read more
HTG Investor Presentation October 2021
button id=”1″]
HTG commences Phase 2 with launch of Opsivity to market
HIGHLIGHTS • Harvest Technology Group Limited wholly owned US subsidiary Harvest Technology Group Inc. announces its rebranding to Opsivity Inc…. Read more
Incannex completes option exercise program to raise A$17.66 million; including A$8.20 million from Chief Medical Officer
Clinical stage cannabinoid and psychedelic medicine development company, Incannex Healthcare Limited (ASX: IHL, ‘Incannex’ or the ‘Company’) is pleased to… Read more
Nyrada Inc (ASX: NYR) Presentation to ASX Small and Mid-Cap Conference
Nyrada Inc (ASX: NYR) is pleased to provide to shareholders and the market generally the corporate presentation that will be… Read more
HTG and Innovation Central Perth to tackle Global Connectivity
Harvest Technology Group Limited (ASX:HTG) (Company) (Harvest) (Group) is pleased to announce it has partnered with Innovation Central Perth (ICP)… Read more
